Evidence map›Paper›PMID 24887397›Full record

ArticlePloS one2014

Changes in abundance of oral microbiota associated with oral cancer.

Brian L Schmidt, Justin Kuczynski, Aditi Bhattacharya, Bing Huey, Patricia M Corby, Erica L S Queiroz, Kira Nightingale, A Ross Kerr, Mark D DeLacure, Ratna Veeramachaneni and 3 more

Erratum issued Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT03418454 (The Oral Microbiome as a Prognostic Tool in Oral Malignant and Premalignant Lesions and in Medication Related Osteonecrosis of the Jaw), which is not on this map. Cited by 215 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
215citing papers in PubMed, 3 pooled it
18.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03418454 unknown statusnot on this mapstarted 2017, after this paper: background citation

The Oral Microbiome as a Prognostic Tool in Oral Malignant and Premalignant Lesions and in Medication Related Osteonecrosis of the Jaw

TypeobservationalSponsorBarzilai Medical CenterRan2017 to 2021Enrolled150ConditionsOral Squamous Cell Carcinoma, Medication Related Osteonecrosis of the Jaw, Oral Epithelial DysplasiaArmsBuccal mucosa samples for Extraction of BACTERIAL DNA
3 · Its place in the literature

Who cites it

215 citing papers in PubMed, 3 syntheses or guidelines pooled it, 375 citations in OpenAlex.

  1. Pooled it
  2. Association of Microbiome with Oral Squamous Cell Carcinoma: A Systematic Review of the Metagenomic Studies.International journal of environmental research and public health · 2021
    Pooled it
  3. The Human Microbiome in Relation to Cancer Risk: A Systematic Review of Epidemiologic Studies.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Differences in the Oral Microbiome Between Patients With and Without Oral Squamous Cell Carcinoma.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2026
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

155 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
    Muy-Teck The [removed]
5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Brian L SchmidtBluestone Center for Clinical Research, New York University College of Dentistry, New York, New York, United States of America; Department of Oral and Maxillofacial Surgery, New York University College of Dentistry, New York, New York, United States of America.
Justin KuczynskiBioinformatics Department, Second Genome, San Bruno, California, United States of America.
Aditi BhattacharyaHelen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, United States of America.
Bing HueyHelen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, United States of America.
Patricia M CorbyBluestone Center for Clinical Research, New York University College of Dentistry, New York, New York, United States of America.
Erica L S QueirozBluestone Center for Clinical Research, New York University College of Dentistry, New York, New York, United States of America.
Kira NightingaleBluestone Center for Clinical Research, New York University College of Dentistry, New York, New York, United States of America.
A Ross KerrDepartment of Oral and Maxillofacial Pathology, Radiology and Medicine, New York University College of Dentistry, New York, New York, United States of America.
Mark D DeLacureDepartments of Otolaryngology and Plastic Surgery, New York University, New York, New York, United States of America.
Ratna VeeramachaneniHelen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, United States of America.
Adam B OlshenHelen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, United States of America.
Donna G AlbertsonHelen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, United States of America.
Muy-Teck Teh
New York University · USUCSF Helen Diller Family Comprehensive Cancer Center · USCenter for Clinical Research (United States) · USUniversity of California, San Francisco · USNew York College of Health Professions · USSecond Genome (United States) · US

Funding

The Role of Proteases and Peptides in Cancer PainR01DE019796 · NIDCR · NEW YORK UNIVERSITY · PI HARDT, MARKUS, SCHMIDT, BRIAN L · 2010 to 2014
$2.8M
Clinical and Transtional Science InstituteTL1RR024129 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$2.0M
Amplicons in Oral DysplasiaR01CA131286 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ALBERTSON, DONNA G · 2008 to 2011
$1.1M
NCI NIH HHS R01 CA131286NCI NIH HHS R21 CA 941186215NCRR NIH HHS TL1 RR024129NCRR NIH HHS UL1 RR024129NIDCR NIH HHS R01 DE019796
6 · The paper itself

Abstract

Individual bacteria and shifts in the composition of the microbiome have been associated with human diseases including cancer. To investigate changes in the microbiome associated with oral cancers, we profiled cancers and anatomically matched contralateral normal tissue from the same patient by sequencing 16S rDNA hypervariable region amplicons. In cancer samples from both a discovery and a subsequent confirmation cohort, abundance of Firmicutes (especially Streptococcus) and Actinobacteria (especially Rothia) was significantly decreased relative to contralateral normal samples from the same patient. Significant decreases in abundance of these phyla were observed for pre-cancers, but not when comparing samples from contralateral sites (tongue and floor of mouth) from healthy individuals. Weighted UniFrac principal coordinates analysis based on 12 taxa separated most cancers from other samples with greatest separation of node positive cases. These studies begin to develop a framework for exploiting the oral microbiome for monitoring oral cancer development, progression and recurrence.

Indexed as

MicrobiotaCase-Control StudiesCohort StudiesHumansMouthMouth Neoplasms

Identifiers

PMID24887397
PMCPMC4041887
OpenAlexW2120335773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.